Literature DB >> 22096616

Nitazoxanide Disrupts Membrane Potential and Intrabacterial pH Homeostasis of Mycobacterium tuberculosis.

Luiz Pedro S de Carvalho1, Crystal M Darby, Kyu Y Rhee, Carl Nathan.   

Abstract

Nitazoxanide (Alinia(®)), a nitro-thiazolyl antiparasitic drug, kills diverse microorganisms by unknown mechanisms. Here we identified two actions of nitazoxanide against Mycobacterium tuberculosis (Mtb): disruption of Mtb's membrane potential and pH homeostasis. Both actions were shared by a structurally related anti-mycobacterial compound, niclosamide. Reactive nitrogen intermediates were reported to synergize with nitazoxanide and its deacetylated derivative tizoxanide in killing Mtb. Herein, however, we could not attribute this to increased uptake of nitazoxanide or tizoxanide as monitored by targeted metabolomics, nor to increased impact of nitazoxanide on Mtb's membrane potential or intrabacterial pH. Thus, further mechanisms of action of nitazoxanide or tizoxanide may await discovery. The multiple mechanisms of action may contribute to Mtb's ultra-low frequency of resistance against nitazoxanide.

Entities:  

Year:  2011        PMID: 22096616      PMCID: PMC3215101          DOI: 10.1021/ml200157f

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN: 1948-5875            Impact factor:   4.345


  31 in total

Review 1.  Acid resistance in Mycobacterium tuberculosis.

Authors:  Omar H Vandal; Carl F Nathan; Sabine Ehrt
Journal:  J Bacteriol       Date:  2009-05-22       Impact factor: 3.490

2.  Structure-activity relationships for a series of quinoline-based compounds active against replicating and nonreplicating Mycobacterium tuberculosis.

Authors:  Annamaria Lilienkampf; Jialin Mao; Baojie Wan; Yuehong Wang; Scott G Franzblau; Alan P Kozikowski
Journal:  J Med Chem       Date:  2009-04-09       Impact factor: 7.446

3.  In vitro evaluation of activities of nitazoxanide and tizoxanide against anaerobes and aerobic organisms.

Authors:  L Dubreuil; I Houcke; Y Mouton; J F Rossignol
Journal:  Antimicrob Agents Chemother       Date:  1996-10       Impact factor: 5.191

Review 4.  Molecular aspects of bacterial pH sensing and homeostasis.

Authors:  Terry A Krulwich; George Sachs; Etana Padan
Journal:  Nat Rev Microbiol       Date:  2011-04-05       Impact factor: 60.633

5.  Nitazoxanide, a potential drug for eradication of Helicobacter pylori with no cross-resistance to metronidazole.

Authors:  F Mégraud; A Occhialini; J F Rossignol
Journal:  Antimicrob Agents Chemother       Date:  1998-11       Impact factor: 5.191

Review 6.  A philosophy of anti-infectives as a guide in the search for new drugs for tuberculosis.

Authors:  Carl Nathan; Ben Gold; Gang Lin; Melanie Stegman; Luiz Pedro Sorio de Carvalho; Omar Vandal; Aditya Venugopal; Ruslana Bryk
Journal:  Tuberculosis (Edinb)       Date:  2008-08       Impact factor: 3.131

7.  Activities of tizoxanide and nitazoxanide compared to those of five other thiazolides and three other agents against anaerobic species.

Authors:  Glenn A Pankuch; Peter C Appelbaum
Journal:  Antimicrob Agents Chemother       Date:  2006-03       Impact factor: 5.191

8.  Improved virologic response in chronic hepatitis C genotype 4 treated with nitazoxanide, peginterferon, and ribavirin.

Authors:  Jean-François Rossignol; Asem Elfert; Yehia El-Gohary; Emmet B Keeffe
Journal:  Gastroenterology       Date:  2008-11-19       Impact factor: 22.682

9.  Nitazoxanide kills replicating and nonreplicating Mycobacterium tuberculosis and evades resistance.

Authors:  Luiz Pedro S de Carvalho; Gang Lin; Xiuju Jiang; Carl Nathan
Journal:  J Med Chem       Date:  2009-10-08       Impact factor: 7.446

10.  Potential for hepatitis C virus resistance to nitazoxanide or tizoxanide.

Authors:  Brent E Korba; Menashe Elazar; Ping Lui; Jean-François Rossignol; Jeffrey S Glenn
Journal:  Antimicrob Agents Chemother       Date:  2008-08-18       Impact factor: 5.191

View more
  51 in total

Review 1.  New antituberculous drugs derived from natural products: current perspectives and issues in antituberculous drug development.

Authors:  Masayuki Igarashi; Yoshimasa Ishizaki; Yoshiaki Takahashi
Journal:  J Antibiot (Tokyo)       Date:  2017-11-01       Impact factor: 2.649

Review 2.  Tuberculosis Drug Development: History and Evolution of the Mechanism-Based Paradigm.

Authors:  Sumit Chakraborty; Kyu Y Rhee
Journal:  Cold Spring Harb Perspect Med       Date:  2015-04-15       Impact factor: 6.915

3.  Methylcitrate cycle defines the bactericidal essentiality of isocitrate lyase for survival of Mycobacterium tuberculosis on fatty acids.

Authors:  Hyungjin Eoh; Kyu Y Rhee
Journal:  Proc Natl Acad Sci U S A       Date:  2014-03-17       Impact factor: 11.205

4.  Thiazolides promote G1 cell cycle arrest in colorectal cancer cells by targeting the mitochondrial respiratory chain.

Authors:  P Ripani; J Delp; K Bode; M E Delgado; L Dietrich; V M Betzler; N Yan; G von Scheven; T U Mayer; M Leist; T Brunner
Journal:  Oncogene       Date:  2019-12-16       Impact factor: 9.867

Review 5.  Potential anti-TB investigational compounds and drugs with repurposing potential in TB therapy: a conspectus.

Authors:  Adetomiwa A Adeniji; Kirsten E Knoll; Du Toit Loots
Journal:  Appl Microbiol Biotechnol       Date:  2020-05-05       Impact factor: 4.813

6.  Activity of nitazoxanide and tizoxanide against Mycobacterium tuberculosis in vitro and in whole blood culture.

Authors:  Elizabeth P Harausz; Keith A Chervenak; Caryn E Good; Michael R Jacobs; Robert S Wallis; Manuel Sanchez-Felix; W Henry Boom
Journal:  Tuberculosis (Edinb)       Date:  2016-03-22       Impact factor: 3.131

7.  New life for an old drug: the anthelmintic drug niclosamide inhibits Pseudomonas aeruginosa quorum sensing.

Authors:  Francesco Imperi; Francesco Massai; Cejoice Ramachandran Pillai; Francesca Longo; Elisabetta Zennaro; Giordano Rampioni; Paolo Visca; Livia Leoni
Journal:  Antimicrob Agents Chemother       Date:  2012-12-17       Impact factor: 5.191

8.  Evolution of a thienopyrimidine antitubercular relying on medicinal chemistry and metabolomics insights.

Authors:  Shao-Gang Li; Catherine Vilchèze; Sumit Chakraborty; Xin Wang; Hiyun Kim; Monica Anisetti; Sean Ekins; Kyu Y Rhee; William R Jacobs; Joel S Freundlich
Journal:  Tetrahedron Lett       Date:  2015-06-03       Impact factor: 2.415

9.  Inhibition of Leishmania mexicana Growth by the Tuberculosis Drug SQ109.

Authors:  Verónica García-García; Eric Oldfield; Gustavo Benaim
Journal:  Antimicrob Agents Chemother       Date:  2016-09-23       Impact factor: 5.191

10.  Structure-activity relationships of antitubercular salicylanilides consistent with disruption of the proton gradient via proton shuttling.

Authors:  Ill-Young Lee; Todd D Gruber; Amanda Samuels; Minhan Yun; Bora Nam; Minseo Kang; Kathryn Crowley; Benjamin Winterroth; Helena I Boshoff; Clifton E Barry
Journal:  Bioorg Med Chem       Date:  2012-11-15       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.